<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="illness and persistent disabling arthritis. The rheumatic symptoms associated with" exact="chikungunya" post="virus (CHIKV) infection include polyarthralgia, polyarthritis, morning stiffness, joint"/>
 <result pre="polyarthralgia, polyarthritis, morning stiffness, joint edema, and erythema. Chronic CHIK" exact="arthritis" post="(CCA) often causes severe pain and associated disability. The"/>
 <result pre="been shown to be effective in preliminary studies in CCA." exact="chikungunya" post="virus chronic chikungunya arthritis pathogenesis methotrexate 1. Introduction Chikungunya"/>
 <result pre="be effective in preliminary studies in CCA. chikungunya virus chronic" exact="chikungunya" post="arthritis pathogenesis methotrexate 1. Introduction Chikungunya virus (CHIKV) is"/>
 <result pre="effective in preliminary studies in CCA. chikungunya virus chronic chikungunya" exact="arthritis" post="pathogenesis methotrexate 1. Introduction Chikungunya virus (CHIKV) is a"/>
 <result pre="of the Togaviridae family [1,2]. Like many other arboviral diseases," exact="chikungunya" post="fever (CHIKF) is transmitted by mosquito vectors, primarily Aedes"/>
 <result pre="and intense fatigue, often accompanied by anorexia, nausea, vomiting, and" exact="diarrhea" post="[9]. In most reports, almost all of the infected"/>
 <result pre="CHIKF lasts approximately 10 days [4]. Neurological complications, including encephalitis," exact="optic neuritis," post="facial paralysis, sensorineural deafness, and Guillain–Barré syndrome, can occur"/>
 <result pre="the disease resolves in some patients, but 25%–40% develop chronic" exact="arthritis" post="that includes musculoskeletal pain, arthralgia, or frank arthritis, lasting"/>
 <result pre="uncertain, there is no existing consensus as to how chronic" exact="chikungunya" post="arthritis (CCA) should be treated. In addition to symptomatic"/>
 <result pre="there is no existing consensus as to how chronic chikungunya" exact="arthritis" post="(CCA) should be treated. In addition to symptomatic treatment"/>
 <result pre="others, there is transient improvement after CHIKF followed by persisitent" exact="arthritis" post="[4,12,23]. In several studies, 25% to 62% of patients"/>
 <result pre="CHIKF [23,24]. Even at the 36-month follow-up, the prevalence of" exact="arthritis" post="has been reported to be as high as 60%"/>
 <result pre="Colombian patients evaluated at 26 weeks after disease onset, persistent" exact="arthritis" post="was found in 54%, morning stiffness in 49%, joint"/>
 <result pre="In a Reunion Island study (2005–2006) of 88 patients, chronic" exact="arthritis" post="occurred in 93%, 57%, and 47% at 3, 15,"/>
 <result pre="24 months, respectively [24]. In another Colombian cohort (2014–2015), persistent" exact="arthritis" post="was less frequent, with 12% affected at the 18-month"/>
 <result pre="polyarthralgia, polyarthritis, morning stiffness, joint edema, and joint redness. CHIK" exact="arthritis" post="often causes severe pain and associated disability [21,27]. The"/>
 <result pre="of whom developed CIR-CHIK classified as mimicking four clinical patterns—rheumatoid" exact="arthritis" post="(RA), seronegative spondyloarthritis (SpA), fibromyalgia (FM), or undifferentiated polyarthritis"/>
 <result pre="as mimicking four clinical patterns—rheumatoid arthritis (RA), seronegative spondyloarthritis (SpA)," exact="fibromyalgia" post="(FM), or undifferentiated polyarthritis (UP), defined as the presence"/>
 <result pre="or undifferentiated polyarthritis (UP), defined as the presence of inflammatory" exact="arthritis" post="affecting more than four joints of greater than 6"/>
 <result pre="2011), 57% developed post-viral polyarthralgia, 22% inflammatory polyarthritis, and 19.5%" exact="tenosynovitis" post="during a 15-month period [29]. Several of these patients’"/>
 <result pre="of these patients’ diseases were reported to mimic RA and" exact="psoriatic arthritis" post="(PsA) [13,30,33]. Similarly, Schilte et al. [25] studied 180"/>
 <result pre="these patients’ diseases were reported to mimic RA and psoriatic" exact="arthritis" post="(PsA) [13,30,33]. Similarly, Schilte et al. [25] studied 180"/>
 <result pre="Similarly, Schilte et al. [25] studied 180 patients with CHIKV" exact="arthritis" post="of 36 months duration in whom the hands, wrists,"/>
 <result pre="affected. Around 60%–80% of the patients had intermittent arthritis, while" exact="arthritis" post="was unremitting in 20%–40%. Among 173 patients with CHIKV"/>
 <result pre="more frequent. In 39 Colombian patients with CHIKF, 90% developed" exact="arthritis" post="that met the RA ACR/EULAR criteria [35]. In a"/>
 <result pre="both RF and anti-CCP antibody. In addition, this patient developed" exact="neutropenia" post="and splenomegaly within 1 year after the onset of"/>
 <result pre="antibody [13,31]. There may be two different groups of chronic" exact="arthritis" post="patients being reported—CCA patients who are negative for RF"/>
 <result pre="while 20 patients (40%) also had arthritis, with clinically evident" exact="synovitis" post="(Figure 1). Arthralgia was most common in the hands"/>
 <result pre="with arthritis, all 20 had hand involvement. Other joints with" exact="arthritis" post="included wrists in 16 (32%), ankles in 12 (24%),"/>
 <result pre="including 6 with &quot;chronic inflammatory rheumatism�? [12]. Sissoko [32] observed" exact="osteoarthritis" post="in 38 of 147 (26%) patients who were followed"/>
 <result pre="small study, Zeana [42] reported preexisting rheumatic disease, including osteoarthritis," exact="carpal tunnel syndrome," post="retrocalcaneal bursitis, and lateral epicondylitis. Essackjee [33] found that"/>
 <result pre="relationship between these conditions and the clinical expression of CHIK" exact="arthritis" post="or the response to treatment [41]. Suggested risk factors"/>
 <result pre="to long-term disease include female sex, age greater than 45," exact="diabetes mellitus," post="hypertension, dyslipidemia, and previous rheumatic disease [43]. In addition,"/>
 <result pre="severe initial CHIKV infection predicted a greater likelihood of long-term" exact="arthritis" post="[44]. 3. Replication Cycle of Chikungunya Virus The transmission"/>
 <result pre="of these cytokines were specific for patients who develop chronic" exact="arthritis" post="[65]. A study of the cytokine profile of patients"/>
 <result pre="pathology and immune activation [73]. In the mouse model, chronic" exact="arthritis" post="may be related to persistent, replicating, transcriptionally active CHIKV"/>
 <result pre="suggesting that viral persistence may not be necessary for persistent" exact="arthritis" post="[75]. The authors suggested that autoantigens or autoreactive lymphocytes"/>
 <result pre="been suggested, including the inhibition of purine and pyrimidine synthesis," exact="suppression" post="of transmethylation reactions with accumulation of polyamines, reduction of"/>
 <result pre="antigen-dependent T-cell proliferation, and promotion of adenosine release with adenosine-mediated" exact="suppression" post="of inflammation [77,78]. In RA, the anti-inflammatory effects of"/>
 <result pre="MTX in animal models of both acute inflammation and adjuvant" exact="arthritis" post="[77,81]. As CCA is similar to RA [26,30,36] and"/>
 <result pre="properties and relationship to the epidemicJ. Hyg (Lond).19565417719110.1017/S002217240004444213346078 6.YactoyoS.StaplesJ.E.MillotV.CibrelusL.Ramon-PardoP.Epidemiology of" exact="chikungunya" post="in the AmericasJ. Infect. Dis.201621444144510.1093/infdis/jiw390 7.WahidB.AliA.RafiqueS.IdreesM.Global expansion of chikungunya"/>
 <result pre="of chikungunya in the AmericasJ. Infect. Dis.201621444144510.1093/infdis/jiw390 7.WahidB.AliA.RafiqueS.IdreesM.Global expansion of" exact="chikungunya" post="virus: Mapping the 64-year historyInt. J. Infect. Dis.201758697610.1016/j.ijid.2017.03.00628288924 8.AmaralJ.K.SchoenR.T.Chikungunya"/>
 <result pre="EmergenceAm. J. Trop. Med. Hyg.20169439339610.4269/ajtmh.15-030826643536 11.MehtaR.GerardinP.de BritoC.SoaresC.N.FerreiraM.SolomonT.The neurological complications of" exact="chikungunya" post="virus: A. systematic reviewRev. Medical. Virol.201828e197810.1002/rmv.1978 12.Rodríguez-MoralesA.J.Cardona-OspinaJ.A.Fernanda Urbano-GarzónS.Sebastian Hurtado-ZapataJ.Prevalence"/>
 <result pre="VirusClin. Microbiol. Rev.201731e00104-1610.1128/CMR.00104-1629237708 16.ReisingerE.C.TschismarovR.BeublerE.WiedermannU.FirbasC.LoebermannM.RamsauerK.Immunogenicity, safety, and tolerability of the measles-vectored" exact="chikungunya" post="virus vaccine MV-CHIK: A double-blind, randomised, placebo-controlled and active-controlled"/>
 <result pre="Patient ManagementArthritis Rheumatol.201710.1002/art.40403 18.SimonF.JavelleE.CabieA.BouquillardE.TroisgrosO.GentileG.Leparc-GoffartI.HoenB.GandjbakhchF.Rene-CorailP.et al.French guidelines for the management of" exact="chikungunya" post="(acute and persistent presentations). November 2014Med. Mal. Infect.20154524326310.1016/j.medmal.2015.05.00726119684 19.Martí-CarvajalA.Ramon-PardoP.JavelleE.SimonF.AldighieriS.HorvathH.ReveizL.Interventions"/>
 <result pre="presentations). November 2014Med. Mal. Infect.20154524326310.1016/j.medmal.2015.05.00726119684 19.Martí-CarvajalA.Ramon-PardoP.JavelleE.SimonF.AldighieriS.HorvathH.ReveizL.Interventions for treating patients with" exact="chikungunya" post="virus infection-related rheumatic and musculoskeletal disorders: A systematic reviewPLoS"/>
 <result pre="and musculoskeletal disorders: A systematic reviewPLoS ONE201712e017902810.1371/journal.pone.017902828609439 20.AmaralJ.K.SutariaR.SchoenR.T.Treatment of chronic" exact="chikungunya" post="arthritis with methotrexate: A systematic reviewArthritis Care Res.201810.1002/acr.23519 21.MarimoutouC.FerraroJ.JavelleE.DeparisX.SimonF.Chikungunya"/>
 <result pre="musculoskeletal disorders: A systematic reviewPLoS ONE201712e017902810.1371/journal.pone.017902828609439 20.AmaralJ.K.SutariaR.SchoenR.T.Treatment of chronic chikungunya" exact="arthritis" post="with methotrexate: A systematic reviewArthritis Care Res.201810.1002/acr.23519 21.MarimoutouC.FerraroJ.JavelleE.DeparisX.SimonF.Chikungunya infection:"/>
 <result pre="studyInt. J. Clin. Pract.2011651306131210.1111/j.1742-1241.2011.02792.x22093538 30.BouquillardÉ.CombeB.A report of 21 cases of" exact="rheumatoid arthritis" post="following Chikungunya fever. A mean follow-up of two yearsJoint."/>
 <result pre="J. Clin. Pract.2011651306131210.1111/j.1742-1241.2011.02792.x22093538 30.BouquillardÉ.CombeB.A report of 21 cases of rheumatoid" exact="arthritis" post="following Chikungunya fever. A mean follow-up of two yearsJoint."/>
 <result pre="6-year experience from Reunion IslandBMC Infect Dis.201414Suppl. 2O2010.1186/1471-2334-14-S2-O20 32.SissokoD.MalvyD.EzzedineK.RenaultP.MoscettiF.LedransM.PierreV.Post epidemic" exact="chikungunya" post="disease on Reunion Island: Course of rheumatic manifestations and"/>
 <result pre="and rheumatoid-like polyarthritis more than 2 years after infection with" exact="chikungunya" post="virusPostgrad. Med. J.20138944044710.1136/postgradmedj-2012-13147723645664 34.ManimundaS.P.VijayachariP.UppoorR.SugunanA.P.SinghS.S.RaiS.K.GuruprasadD.R.Clinical progression of chikungunya fever during"/>
 <result pre="after infection with chikungunya virusPostgrad. Med. J.20138944044710.1136/postgradmedj-2012-13147723645664 34.ManimundaS.P.VijayachariP.UppoorR.SugunanA.P.SinghS.S.RaiS.K.GuruprasadD.R.Clinical progression of" exact="chikungunya" post="fever during acute and chronic arthritic stages and the"/>
 <result pre="39 cases in ColombiaClin. Rheumatol.20153583183210.1007/s10067-015-3041-826242471 36.MinerJ.J.Aw YeangH.X.FoxJ.M.TaffnerS.MalkovaO.N.OhS.T.KimA.H.J.DiamondM.S.LenschowD.J.YokoyamaW.M.Brief report: Chikungunya viral" exact="arthritis" post="in the united states: A mimic of seronegative rheumatoid"/>
 <result pre="states: A mimic of seronegative rheumatoid arthritisArthritis Rheumatol.2015671214122010.1002/art.3902725605621 37.ChaaithanyaI.K.MuruganandamN.RaghurajU.SugunanA.P.RajeshR.AnweshM.VijayachariP.Chronic inflammatory" exact="arthritis" post="with persisting bony erosions in patients following chikungunya infectionIndian"/>
 <result pre="37.ChaaithanyaI.K.MuruganandamN.RaghurajU.SugunanA.P.RajeshR.AnweshM.VijayachariP.Chronic inflammatory arthritis with persisting bony erosions in patients following" exact="chikungunya" post="infectionIndian J. Med. Res.2014140142145Retrieved March 10, 201725222790 38.ChopraA.AnuradhaV.Lagoo-JoshiV.KunjirV.SalviS.SalujaM.Chikungunya virus"/>
 <result pre="return from the CaribbeanTravel Med. Infect. Dis.201614212510.1016/j.tmaid.2016.01.00926872414 43.GérardinP.FianuA.MichaultA.MussardC.BoussaïdK.RollotO.GrivardP.KassabS.BouquillardE.BorgheriniG.et al.Predictors of" exact="chikungunya" post="rheumatism: A prognostic survey ancillary to the TELECHIK cohort"/>
 <result pre="studyArthritis Res. Ther.201315R910.1186/ar413723302155 44.YaseenH.M.SimonF.DeparisX.MarimoutouC.Identification of initial severity determinants to predict" exact="arthritis" post="after chikungunya infection in a cohort of French gendarmesBMC"/>
 <result pre="Ther.201315R910.1186/ar413723302155 44.YaseenH.M.SimonF.DeparisX.MarimoutouC.Identification of initial severity determinants to predict arthritis after" exact="chikungunya" post="infection in a cohort of French gendarmesBMC Musculoskelet Disord.20141510.1186/1471-2474-15-249"/>
 <result pre="as Targets of Chikungunya Virus InfectionPLoS ONE.20072e52710.1371/journal.pone.000052717565380 52.SourisseauM.SchwartzO.Characterization of reemerging" exact="chikungunya" post="virusPlos Pathog.200730804081710.1371/journal.ppat.0030089 53.AshokA.AtwoodW.J.Contrasting Roles of Endosomal pH and the"/>
 <result pre="cellular and chemicalCell Death Differ.200614737810.1038/sj.cdd.440203416946729 59.SchilteC.CoudercT.ChretienF.SourisseauM.GangneuxN.Guivel-BenhassineF.KraxnerA.TschoppJ.HiggsS.MichaultA.et al.Type I IFN controls" exact="chikungunya" post="virus via its action on nonhematopoietic cellsJ. Exp. Med.201020742944210.1084/jem.2009085120123960"/>
 <result pre="an Innate Immune ResponseJ. Immunol.20101845903591310.4049/jimmunol.090418120404274 61.ChirathawornC.L.PoovorawanY.LertmaharitS.WuttirattanakowitN.Cytokine levels in patients with" exact="chikungunya" post="virus infectionAsian Pac. J. Trop Med.2013663163410.1016/S1995-7645(13)60108-X23790334 62.MinerJ.J.LenschowD.J.Editorial: Lessons Learned"/>
 <result pre="Rheumatol.20187047747910.1002/art.4042129361204 63.HoarauJ.J.Jaffar BandjeeM.C.Krejbich TrototP.DasT.Li-Pat-YuenG.DassaB.GuichardE.RiberaA.HenniT.TalletF.et al.Persistent chronic inflammation and infection by" exact="chikungunya" post="arthritogenic alphavirus in spite of a robust host immune"/>
 <result pre="responseJ. Immunol.20101845914592710.4049/jimmunol.090025520404278 64.ChaaitanyaI.K.MuruganandamN.SundaramS.G.KawalekarO.SugunanA.P.ManimundaS.P.GhosalS.R.MuthumaniK.VijayachariP.Role of pro-inflammatory cytokines and chemokines in chronic" exact="arthropathy" post="in CHIKV infectionViral. Immunol.20112426527110.1089/vim.2010.012321830898 65.ChowA.HerZ.OngE.K.ChenJ.DimatatacF.KwekD.J.NgL.F.Persistent Arthralgia Induced by Chikungunya"/>
 <result pre="cell functionality and increased TNF-α production as biomarkers of chronic" exact="chikungunya" post="arthritis and rheumatoid arthritisHum. Immunol.20177837037410.1016/j.humimm.2017.02.00628213049 73.McCarthyM.K.MorrisonT.E.Chronic chikungunya virus musculoskeletal"/>
 <result pre="functionality and increased TNF-α production as biomarkers of chronic chikungunya" exact="arthritis" post="and rheumatoid arthritisHum. Immunol.20177837037410.1016/j.humimm.2017.02.00628213049 73.McCarthyM.K.MorrisonT.E.Chronic chikungunya virus musculoskeletal disease:"/>
 <result pre="biomarkers of chronic chikungunya arthritis and rheumatoid arthritisHum. Immunol.20177837037410.1016/j.humimm.2017.02.00628213049 73.McCarthyM.K.MorrisonT.E.Chronic" exact="chikungunya" post="virus musculoskeletal disease: What are the underlying mechanisms?Future Microbiol.20161133133410.2217/fmb.15.14726939523"/>
 <result pre="74.PooY.S.RuddP.A.GardnerJ.WilsonJ.A.LarcherT.SuhrbierA.Multiple immune factors are involved in controlling acute and chronic" exact="chikungunya" post="virus infectionPLoS Negl. Trop Dis.20148e335410.1371/journal.pntd.000335425474568 75.ChangA.Y.MartinsK.A.EncinalesL.ReidS.P.AcuñaM.EncinalesC.FiresteinG.S.Chikungunya Arthritis Mechanisms in"/>
 <result pre="Woman, 82 years old, 2 years after CHIKV infection. Intense" exact="arthritis" post="of metacarpophalangeal joints and wrist. Figure 2 Cytokines that"/>
</results>
